Infographic: Mechanisms of Resistance

Cancers appear to be able to evolve resistance to many of the therapies doctors have tried.

By | April 1, 2017

Primary Versus Acquired Resistance

Cancer cells can evolve ways to evade a drug’s attack, or they may already be resistant prior to treatment.


Examples of Acquired Resistance

Resistance to chemotherapy likely encompasses a broad range of mechanisms having to do with DNA repair, cell cycle arrest, apoptotic pathways, and others, many of which are still unknown. When it comes to molecular-targeted agents and immunotherapies, however, research has nailed down some basic strategies.


Mutations within the target protein can prevent drug binding, or keep the protein active despite drug binding.


Mutations can restore cellular signaling by affecting a downstream gene or by activating a bypass pathway.


Tumor cells can lose characteristics of their typical cell type and acquire characteristics of a different lineage that does not depend on signaling blocked by the cancer drug.


Mutations can render tumor cells less recognizable to the immune system or less responsive to molecular signals from immune cells.


Mutations and other changes alter the target protein. These can include altered splicing of the tumor target, which blocks recognition by the engineered T cell.

Read the full story


Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Male Fish Borrows Egg to Clone Itself
  2. How to Tell a Person’s “Brain Age”
  3. Life Science Funding Cuts Leaked
    The Nutshell Life Science Funding Cuts Leaked

    According to a document posted online less than a day before the release of the official 2018 budget proposal, the National Institutes of Health could face even deeper cuts than previously suggested by the Trump administration.

  4. Cooking Up Cancer?
    Notebook Cooking Up Cancer?

    Overcooked potatoes and burnt toast contain acrylamide, a potential carcinogen that researchers have struggled to reliably link to human cancers.